Ameritas Investment Partners’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
Ameritas Investment Partners's ORGO Position: Q2 2026 in Review
Ameritas Investment Partners held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 5,386 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.
Ameritas Investment Partners first reported a position in ORGO in Q2 2019 and has held it in 29 quarters since. The position peaked at $50K in Q2 2021. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.
- Ameritas Investment Partners held 5,386 shares of Organogenesis Holdings worth $13.1K as of Q2 2026.
- Ameritas Investment Partners left its Organogenesis Holdings share count unchanged in Q2 2026.
- Organogenesis Holdings made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2941 holding.
- Ameritas Investment Partners first reported a position in Organogenesis Holdings in Q2 2019 and has held it in 29 quarters since.
- Ameritas Investment Partners's Organogenesis Holdings position peaked at $50K in Q2 2021.
- 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.